Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Liudmila P. Smirnova"'
Autor:
Elena V. Epimakhova, Liudmila P. Smirnova, Daria V. Kazantseva, Daria A. Kamaeva, Svetlana A. Ivanova
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 4, Pp 3168-3179 (2023)
Numerous studies indicate the involvemen of oxidative stress in the pathogenesis of schizophrenia. It has been shown that the serum pool of antibodies in patients with schizophrenia contains catalytically active antibodies (abzymes) that have a wide
Externí odkaz:
https://doaj.org/article/5c5d4a3a951a4ae1abcb8a52d055b285
Autor:
Natalia V. Yunusova, Natalia O. Popova, Irina N. Udintseva, Tatyana S. Klyushina, Daria V. Kazantseva, Liudmila P. Smirnova
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 4, Pp 3302-3314 (2023)
Extracellular vesicles (EVs) as membrane structures of cellular origin participating in intercellular communication are involved in the molecular mechanisms of the development of various variants of polyneuropathy. Taking into account the increasing
Externí odkaz:
https://doaj.org/article/79e4ef48a2854136baf0aff1d4660cd1
Autor:
Liudmila P. Smirnova, Vasily L. Yarnykh, Daria A. Parshukova, Elena G. Kornetova, Arkadiy V. Semke, Anna V. Usova, Anna O. Pishchelko, Marina Y. Khodanovich, Svetlana A. Ivanova
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Myelin deficiency is commonly recognized as an important pathological feature of brain tissues in schizophrenia (SZ). In this pilot study, global myelin content abnormalities in white matter (WM) and gray matter (GM) of SZ patients were non-
Externí odkaz:
https://doaj.org/article/ab44e78f886240eb8bf5e3fb5b6cd237
Autor:
Daria A. Kamaeva, Daria V. Kazantseva, Anastasiia S. Boiko, Irina A. Mednova, Liudmila P. Smirnova, Elena G. Kornetova, Svetlana A. Ivanova
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1179 (2023)
Catalytic antibodies, or abzymes, are capable of not only binding but also hydrolyzing various proteins. Previously, an increase in the level of myelin basic protein (MBP)-hydrolyzing activity of antibodies was shown in patients with a number of neur
Externí odkaz:
https://doaj.org/article/e3a17c9899ee49d78afa205b2cb3e507
Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia
Autor:
Daria A. Parshukova, Liudmila P. Smirnova, Elena G. Kornetova, Arkadiy V. Semke, Valentina N. Buneva, Svetlana A. Ivanova
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
The level hydrolysis of myelin basic protein (MBP) by IgG in patients with schizophrenia was studied depending on the clinical features and course of the disease. The patients were grouped according to type of schizophrenia and type of disease course
Externí odkaz:
https://doaj.org/article/db7c90da89fd4ab098c961942bdbf158
Autor:
Liudmila M. Smirnova
Publikováno v:
Гений oртопедии, Vol 24, Iss 1, Pp 50-56 (2018)
Introduction Patients after unilateral lower limb amputation have the compensatory overloading of the contralateral (intact) limb which can lead to an additional decline in their quality of life. Purpose To determine reliable biomechanical indicators
Externí odkaz:
https://doaj.org/article/d2806dad4115423ab1cdcd7cf82406d1
Autor:
Daria A. Kamaeva, Liudmila P. Smirnova, Svetlana N. Vasilieva, Daria V. Kazantseva, Alisa R. Vasilieva, Svetlana A. Ivanova
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 13; Pages: 7397
The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myel
Autor:
Irina A. Mednova, Liudmila P. Smirnova, Alisa R. Vasilieva, Daria V. Kazantseva, Elena V. Epimakhova, Nina M. Krotenko, Arkadiy V. Semke, Svetlana A. Ivanova
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 9; Pages: 1449
This study aimed to evaluate the superoxide dismutase (SOD) activity of IgG in patients with schizophrenia. After signing informed consent, we included 67 patients with schizophrenia (34 people with acute schizophrenia and 33 individuals were on outp